Benjamin Tilewick - Phenixfin Senior Analyst
| PFX Stock | USD 44.56 0.00 0.00% |
Executive
Benjamin Tilewick is Senior Analyst of Phenixfin
| Address | 445 Park Avenue, New York, NY, United States, 10022 |
| Phone | 212-859-0390 |
| Web | https://www.phenixfc.com/ |
Phenixfin Management Efficiency
The company has Return on Asset of 0.0311 % which means that on every $100 spent on assets, it made $0.0311 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0259 %, implying that it generated $0.0259 on every 100 dollars invested. Phenixfin's management efficiency ratios could be used to measure how well Phenixfin manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.000016 in 2026. Return On Capital Employed is likely to rise to 0.000054 in 2026. At this time, Phenixfin's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 1.2 B in 2026, whereas Debt To Assets are likely to drop 0.0005 in 2026.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Max Kaplan | Sol Strategies Common | N/A | |
| Joshua Wein | Hennessy Ad | N/A | |
| CFA Ragozzino | Sol Strategies Common | N/A | |
| Mukya Porter | OFS Capital Corp | 52 | |
| Kyle Spina | OFS Capital Corp | 38 | |
| Daniel Hennessy | Hennessy Ad | N/A | |
| Richard JD | OFS Capital Corp | 67 | |
| Shi Jiaxing | Highest Performances Holdings | 34 | |
| John Ragozzino | Sol Strategies Common | N/A | |
| Mukya JD | OFS Capital Corp | 51 | |
| Jeff Stewart | Auburn National Bancorporation | N/A | |
| Jing He | Highest Performances Holdings | N/A | |
| Andrew McDonald | Sol Strategies Common | N/A | |
| Adam JD | Great Elm Capital | 51 | |
| Jennifer Cheskiewicz | Hennessy Ad | 46 | |
| Jennifer Emerson | Hennessy Ad | 48 | |
| Tod JD | OFS Capital Corp | 64 | |
| Tung Lui | Bluemount Holdings Limited | 55 | |
| Alan Hennessy | Hennessy Ad | N/A | |
| Greg Pettey | Auburn National Bancorporation | N/A | |
| Wayne CPA | Auburn National Bancorporation | 75 | |
Management Performance
| Return On Equity | 0.0259 | |||
| Return On Asset | 0.0311 |
Phenixfin Leadership Team
Elected by the shareholders, the Phenixfin's board of directors comprises two types of representatives: Phenixfin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Phenixfin. The board's role is to monitor Phenixfin's management team and ensure that shareholders' interests are well served. Phenixfin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Phenixfin's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ryan Phalen, Managing Director | ||
| Gerald Cummins, Chief Officer | ||
| Benjamin Tilewick, Senior Analyst | ||
| Chris Cannellos, Controller | ||
| Ellida CPA, Chief Officer | ||
| Joshua Coleman, Vice President | ||
| Therese Dyman, Controller | ||
| David Lorber, Chairman CEO |
Phenixfin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Phenixfin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Phenixfin Stock Analysis
When running Phenixfin's price analysis, check to measure Phenixfin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phenixfin is operating at the current time. Most of Phenixfin's value examination focuses on studying past and present price action to predict the probability of Phenixfin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phenixfin's price. Additionally, you may evaluate how the addition of Phenixfin to your portfolios can decrease your overall portfolio volatility.